Decision Diagnostics Net Profit Margin 2010-2011 | DECN

Decision Diagnostics net profit margin from 2010 to 2011. Net profit margin can be defined as net Income as a portion of total sales revenue.
Decision Diagnostics Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2011-09-30 $0.02B $0.00B -6.25%
2011-06-30 $0.02B $0.00B -5.88%
2011-03-31 $0.02B $0.00B -5.56%
2010-12-31 $0.02B $0.00B -5.26%
2010-09-30 $0.02B 0 0.00%
2010-06-30 $0.02B 0 0.00%
2010-03-31 $0.02B $0.00B 5.56%
2009-12-31 $0.02B $0.00B 5.26%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.000B $0.000B
Decision Diagnostics Corp. is engaged in developing products that offer solutions in medical care and management by providing physicians with information at the point of care. The Company uses smart phones which allow physicians to carry, access and update their patients' histories, medication data, and best care guidelines at the point of care. Decision Diagnostics Corp. is a leading provider of prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary cell phone centric e-health products and technologies. Decision Diagnostics Corp., formerly known as Instacare Corp., is based in Westlake Village, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.877B 52.32
Hims & Hers Health (HIMS) United States $10.991B 115.05
Tempus AI (TEM) United States $8.988B 0.00
Inspire Medical Systems (INSP) United States $4.774B 74.60
IRhythm Technologies (IRTC) United States $4.316B 0.00
Privia Health (PRVA) United States $2.756B 206.54
Enovis (ENOV) United States $1.947B 12.05
Schrodinger (SDGR) United States $1.721B 0.00
Clover Health Investments (CLOV) United States $1.712B 0.00
Phreesia (PHR) United States $1.426B 0.00
Omnicell (OMCL) United States $1.202B 21.21
Azenta (AZTA) United States $1.162B 54.08
10x Genomics (TXG) United States $0.991B 0.00
Fulgent Genetics (FLGT) United States $0.573B 0.00
Talkspace (TALK) United States $0.530B 157.25
Butterfly Network (BFLY) United States $0.527B 0.00
Veradigm (MDRX) United States $0.486B 0.00
Standard BioTools (LAB) United States $0.403B 0.00
TruBridge (TBRG) United States $0.381B 0.00
Claritev (CTEV) United States $0.329B 0.00
Health Catalyst (HCAT) United States $0.286B 0.00
Nyxoah SA (NYXH) Belgium $0.218B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
Pulmonx (LUNG) United States $0.138B 0.00
American Well (AMWL) United States $0.106B 0.00
Retrieve Medical Holdings (RMHI) United States $0.095B 0.00
EUDA Health Holdings (EUDA) Singapore $0.092B 0.00
CareCloud (CCLD) United States $0.091B 3.45
MDxHealth SA (MDXH) Belgium $0.080B 0.00
111 (YI) China $0.069B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.062B 0.00
Outset Medical (OM) United States $0.041B 0.00
Zepp Health (ZEPP) Netherlands $0.040B 0.00
Zhongchao (ZCMD) China $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00